Condition: Catheter Blockage · Oncology · Kidney Stone · Sponsor: University of Southampton
Urological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, negatively impacting on QoL and mental health. Offering novel designs with significantly lower E\&B leads to a reduction in UTIs and improves QoL. Reducing hospital admissions (from 3 to 1 per patient, annually) would free \>100,000 bed-nights, allowing the elderly to regain independence. Our proposed research could have a significant impact towards fulfilling the 'healthy-ageing' Grand Challenge. Additionally, the novel stent reduces prevalence of infections and therefore, of antibiotic prescriptions contributing to the Global AMR challenge.
This description comes directly from the study's public registry record.
Ali Mosayyebi · 02380594767 · a.mosayyebi@soton.ac.uk
Sophie Varkonyi-Clifford · 02381203866 · cassette@soton.ac.uk
Always discuss trial participation with your own doctor first.
| University Hospital Southampton | Southampton, England, United Kingdom | Recruiting |
| University College Hospital London | London, London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06815120